Solventum Aktie News

EAGAN, Minn., May 27, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the Jefferies Healthcare Conference on Wednesday, Jun. 3, 2026, beginning at approximately 9:55 a.m.

Solventum Corporation (SOLV) Presents at Bank of America Global Healthcare Conference 2026 Transcript

ST. PAUL, Minn., May 7, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the BofA Securities Health Care Conference on Wednesday, May 13, 2026, beginning at approximately 10:00 a.m.

Solventum Corporation (SOLV) Q1 2026 Earnings Call Transcript

Medical device maker Solventum said on Tuesday it expects annual profit to be at the higher ​end of its previous forecast range, primarily driven ‌by strong demand for its wound care and sterilization products.

Reported sales decreased (3.0)%; organic sales increased 2.1% Affirms full-year 2026 organic sales growth and free cash flow guidance; estimates adjusted EPS will be toward the high end of existing range EAGAN, Minn., May 5, 2026 /PRNewswire/ -- Solventum (NYSE: SOLV) today reported financial results for the first quarter ended March 31, 2026.

Nelson Peltz's Trian Fund Management on Thursday called on Solventum to rightsize overhead costs, ​divest non-core businesses and improve capital allocation in its ‌latest appeal for a performance turnaround at the medical device maker.

Solventum's Spin-Out from 3M has Maximized Executive Compensation, Not Shareholder Value Outlines Three Initiatives to Improve Performance and Drive Value Creation at Solventum NEW YORK, April 30, 2026 (GLOBE NEWSWIRE) -- Trian Fund Management, L.P. (“Trian”), which beneficially owns nearly 5% of Solventum Corporation's common stock (NYSE: SOLV) (“Solventum” or the “Company”) and is one of the ...